These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 28042952

  • 1. Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.
    Wang M, Li G, Yang Z, Wang L, Zhang L, Wang T, Zhang Y, Zhang S, Han Y, Jia L.
    Oncotarget; 2017 Jan 31; 8(5):8083-8094. PubMed ID: 28042952
    [Abstract] [Full Text] [Related]

  • 2. Reduced SLC27A2 induces cisplatin resistance in lung cancer stem cells by negatively regulating Bmi1-ABCG2 signaling.
    Su J, Wu S, Tang W, Qian H, Zhou H, Guo T.
    Mol Carcinog; 2016 Nov 31; 55(11):1822-1832. PubMed ID: 26513225
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X, Liu X, Chi W, Liu Y, Wei L, Wang X, Yu J.
    Cancer Chemother Pharmacol; 2006 Dec 31; 58(6):776-84. PubMed ID: 16532342
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of ABCG2 via the PI3K-Akt pathway contributes to acidic microenvironment-induced cisplatin resistance in A549 and LTEP-a-2 lung cancer cells.
    Hu CF, Huang YY, Wang YJ, Gao FG.
    Oncol Rep; 2016 Jul 31; 36(1):455-61. PubMed ID: 27221310
    [Abstract] [Full Text] [Related]

  • 5. Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells.
    Zhan L, Zhang H, Zhang Q, Woods CG, Chen Y, Xue P, Dong J, Tokar EJ, Xu Y, Hou Y, Fu J, Yarborough K, Wang A, Qu W, Waalkes MP, Andersen ME, Pi J.
    Free Radic Biol Med; 2012 Aug 15; 53(4):758-68. PubMed ID: 22684020
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CXCR4 promotes cisplatin-resistance of non-small cell lung cancer in a CYP1B1-dependent manner.
    Xie S, Tu Z, Xiong J, Kang G, Zhao L, Hu W, Tan H, Tembo KM, Ding Q, Deng X, Huang J, Zhang Q.
    Oncol Rep; 2017 Feb 15; 37(2):921-928. PubMed ID: 27922681
    [Abstract] [Full Text] [Related]

  • 8. ABCB1 and ABCG2 drug transporters are differentially expressed in non-small cell lung cancers (NSCLC) and expression is modified by cisplatin treatment via altered Wnt signaling.
    Vesel M, Rapp J, Feller D, Kiss E, Jaromi L, Meggyes M, Miskei G, Duga B, Smuk G, Laszlo T, Karner I, Pongracz JE.
    Respir Res; 2017 Mar 24; 18(1):52. PubMed ID: 28340578
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer.
    Salaroglio IC, Belisario DC, Akman M, La Vecchia S, Godel M, Anobile DP, Ortone G, Digiovanni S, Fontana S, Costamagna C, Rubinstein M, Kopecka J, Riganti C.
    J Exp Clin Cancer Res; 2022 Aug 11; 41(1):243. PubMed ID: 35953814
    [Abstract] [Full Text] [Related]

  • 13. Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1α in vitro.
    Wang WJ, Sui H, Qi C, Li Q, Zhang J, Wu SF, Mei MZ, Lu YY, Wan YT, Chang H, Guo PT.
    Oncol Rep; 2016 Jul 11; 36(1):428-40. PubMed ID: 27221674
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X, Lin D, Low C, Vucic EA, English JC, Yee J, Murray N, Lam WL, Ling V, Lam S, Gout PW, Wang Y.
    J Thorac Oncol; 2013 Feb 11; 8(2):161-70. PubMed ID: 23287853
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines.
    Tang Y, Hou J, Li G, Song Z, Li X, Yang C, Liu W, Hu Y, Xu Y.
    Oncol Rep; 2014 Nov 11; 32(5):2168-74. PubMed ID: 25200103
    [Abstract] [Full Text] [Related]

  • 20. Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions.
    Lee JG, Shin JH, Shim HS, Lee CY, Kim DJ, Kim YS, Chung KY.
    Respir Res; 2015 Nov 09; 16():138. PubMed ID: 26553068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.